MeSH tree: E02.880.820.790
Adding two weeks of continuous positive airway pressure for preterm infants in the hospital substantially improves lung growth and function, according to new research from Oregon Health & Science University.
Apr 17, 2025
0
10
Last year, two popular smartwatches—the Samsung Galaxy Watch and Apple Watch—received Food and Drug Administration approval for features that can potentially alert the wearer that they may have sleep apnea.
Apr 16, 2025
0
17
Continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea is most effective in improving neurocognition in people who have a high arousal threshold, according to a new research analysis. The study, published ...
Feb 24, 2025
0
20
Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in Otolaryngology–Head and Neck Surgery reveals that for people with sleep apnea, getting surgery for their ...
Jan 22, 2025
0
21
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.
Dec 23, 2024
0
72
Continuous positive airway pressure, or CPAP, therapy can improve the lives of people with obstructive sleep apnea, but nearly half of adults with CPAP machines fail to adhere to a regular regimen of CPAP use. A new University ...
Dec 4, 2024
0
15
A Center for Eye Research Australia study has linked low levels of oxygen in the blood overnight—a common sign of obstructive sleep apnea—with wet age-related macular degeneration.
Dec 4, 2024
0
44
An unhealthy diet and an indolent life are well known causes of heart disease and stroke. But sleep apnea—where people temporarily stop breathing while asleep because their airway collapses—is also a major risk factor for ...
Nov 12, 2024
0
25
Dr. Virend Somers, a Mayo Clinic cardiologist with a focus on sleep apnea, says it's a serious medical condition that can cause heart problems and other health issues. Dr. Somers co-authored a study published in the Journal ...
Oct 10, 2024
0
64
Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnea (OSA), according to results of a clinical trial presented at the European Respiratory Society ...
Sep 10, 2024
0
33
